Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim
Johnson and Johnson
Moodys
Dow
McKinsey

Last Updated: January 27, 2023

CLINICAL TRIALS PROFILE FOR HYDROXOCOBALAMIN


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


All Clinical Trials for Hydroxocobalamin

Trial ID Title Status Sponsor Phase Start Date Summary
NCT01147289 ↗ Efficacy and Safety of Injectable Association of Dexamethasone, Dipyrone and Hydrocobalamin in Lumbar Sciatic Pain Completed Eurofarma Laboratorios S.A. Phase 3 2011-02-01 A phase III, randomized, multicenter, open label clinical trial to evaluate efficacy and safety of the injectable association of dexamethasone, dipyrone, and hydroxocobalamin in lumbar sciatic pain. The study will enroll 140 patients in each arm (280 total).
NCT01656616 ↗ Hydroxycobalamin and Rural Emergency Medical Services Cyanide Exposure Patients: A Cost Analysis Withdrawn Maine Medical Center 2012-08-01 The costs to a rural emergency medical services (EMS) system of a change from a traditional cyanide antidote kit to a kit containing hydroxocobalamin alone are currently unknown. The purpose of this study is to use current EMS data to calculate the costs to a rural EMS system associated with the adoption of a hydroxocobalamin protocol for the treatment of suspected cyanide exposure.
NCT01656616 ↗ Hydroxycobalamin and Rural Emergency Medical Services Cyanide Exposure Patients: A Cost Analysis Withdrawn MaineHealth 2012-08-01 The costs to a rural emergency medical services (EMS) system of a change from a traditional cyanide antidote kit to a kit containing hydroxocobalamin alone are currently unknown. The purpose of this study is to use current EMS data to calculate the costs to a rural EMS system associated with the adoption of a hydroxocobalamin protocol for the treatment of suspected cyanide exposure.
NCT02270749 ↗ Vitamin Deficiencies and Suppletion in Morbid Obesity Completed Rijnstate Hospital Phase 4 2014-10-01 The purpose of this study is to evaluate the most effective treatment for patients who underwent a Roux-en-Y gastric bypass and developed postoperatively a vitamin B12 deficiency.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Hydroxocobalamin

Condition Name

Condition Name for Hydroxocobalamin
Intervention Trials
Vasoplegic Syndrome 2
Cardiac Surgery Using Cardiopulmonary Bypass 1
Septic Shock 1
Cardiac Valve Disease 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Hydroxocobalamin
Intervention Trials
Vasoplegia 3
Syndrome 2
Shock, Septic 1
Obesity, Morbid 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Hydroxocobalamin

Trials by Country

Trials by Country for Hydroxocobalamin
Location Trials
United States 8
Brazil 3
Saudi Arabia 2
Mexico 1
Netherlands 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Hydroxocobalamin
Location Trials
Massachusetts 2
New York 1
Florida 1
Wisconsin 1
Minnesota 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Hydroxocobalamin

Clinical Trial Phase

Clinical Trial Phase for Hydroxocobalamin
Clinical Trial Phase Trials
Phase 4 3
Phase 3 1
Phase 2 4
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Hydroxocobalamin
Clinical Trial Phase Trials
Recruiting 5
Completed 3
Withdrawn 2
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Hydroxocobalamin

Sponsor Name

Sponsor Name for Hydroxocobalamin
Sponsor Trials
Mayo Clinic 2
Dartmouth-Hitchcock Medical Center 1
Medical College of Wisconsin 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Hydroxocobalamin
Sponsor Trials
Other 10
Industry 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Moodys
McKesson
Merck
AstraZeneca
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.